Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NUTX | Nutex Health, Inc. | 2026-04-02 15:10:04 | 100.92 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUTX | 0001479681 | Nutex Health Inc. | US67079U3068 | 254900RSD2OET3HENJ50 | 113363609 | Nasdaq | 7389 | Services-Business Services, NEC | 1231 | DE | 1776 YORKTOWN ST | HOUSTON | TX | 77056 | UNITED STATES | US | (713) 660-0557 | 1776 YORKTOWN ST, HOUSTON, TX, 77056 | 1776 YORKTOWN ST, HOUSTON, TX, 77056 | Nutex Health, Inc. | — | — | Thomas Vo | — | http://nutexhealth.com | 524,000,000 | 7,086,670 | 6,968,350 | Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas. | 2026-04-02 17:42:03 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 524,000,000 | 505,800,000 | 2,779.1209 | 6,968,350 | 1,017,811 | 17.1045 |
| 2024 | 18,200,000 | -127,000,000 | -87.4656 | 5,950,539 | -739,476,320 | -99.2017 |
| 2023 | 145,200,000 | -888,800,000 | -85.9574 | 745,426,859 | 94,500,734 | 14.5179 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Wesley Bamburg | Chief Operating Officer | 2025 | 79,808 | 25,000 | — | — | 1,164 | 105,972 |
| Joshua Detillio | Chief Operating Officer | 2025 | 269,712 | 297,500 | — | — | 30,236 | 952,132 |
| Thomas T. Vo | Chief Executive Officer | 2025 | 1,000,000 | 504,880 | — | — | 22,590 | 2,197,420 |
| Warren Hosseinion | President | 2025 | 755,100 | 382,430 | — | — | 61,986 | 1,705,421 |
| Michael Chang | Chief Medical Officer | 2025 | 394,231 | 129,880 | — | — | 24,986 | 716,585 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 944 |
| 2024 | 800 |
| 2023 | 800 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 875,257,000 | 479,948,633 | 247,646,316 |
| Cost Of Revenue | — | — | — |
| Gross Profit | 444,281,000 | 196,261,277 | 34,774,171 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 51,653,000 | 41,923,972 | 33,229,718 |
| Operating Expenses | 168,656,000 | 65,563,477 | 66,547,919 |
| Operating Income | 275,625,000 | 130,697,800 | -31,773,748 |
| Net Income | 70,789,000 | 52,096,040 | -45,786,614 |
| Earnings Per Share Basic | 11.13 | 10.23 | -0.07 |
| Earnings Per Share Diluted | 10.48 | 9.69 | -0.07 |
| Weighted Average Shares Outstanding Basic | 6,361,427 | 5,090,787 | 661,247,959 |
| Weighted Average Shares Outstanding Diluted | 6,756,108 | 5,491,676 | 654,094,485 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 185,574,000 | 40,640,616 | 22,002,056 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 6,000,000 | 4,300,000 | 58,624,301 |
| Inventories | 2,866,000 | 2,849,814 | 3,390,584 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | 248,897,473 | — |
| Total Assets Current | 538,811,000 | 292,478,885 | 90,848,403 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 94,581,000 | 77,932,744 | 81,387,649 |
| Other Assets Non Current | 662,000 | — | 33,089,636 |
| Total Assets Non Current | 379,714,000 | 362,841,508 | 307,397,094 |
| Total Assets | 918,525,000 | 655,320,393 | 398,245,497 |
| Accounts Payable | 45,863,000 | 9,613,821 | 18,899,196 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 13,336,000 | 14,395,457 | 10,808,721 |
| Other Liabilities Current | — | 110,531,725 | 6,364,586 |
| Total Liabilities Current | 157,911,000 | 154,226,190 | 58,313,052 |
| Long Term Debt | 29,174,000 | 22,465,896 | 26,314,733 |
| Other Liabilities Non Current | — | 312,562,391 | — |
| Total Liabilities Non Current | 18,442,000 | 11,768,239 | 12,959,171 |
| Total Liabilities | 495,088,000 | 466,788,581 | 319,139,391 |
| Common Stock | 7,000 | 5,511 | 676,680 |
| Retained Earnings | -286,187,000 | -356,976,499 | -409,072,539 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 329,447,000 | 132,437,993 | 61,453,190 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 20,530,000 | 18,971,972 | 17,591,572 |
| Share Based Compensation Expense | — | 16,300,000 | 935,967 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 86,943,000 | 173,956,924 | 969,761 |
| Change In Inventories | 16,000 | -540,770 | -142,701 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 0 | 3,539,372 | -4,715,101 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 248,125,000 | 23,153,807 | 1,256,452 |
| Purchases Of Marketable Securities | — | 2,940,796 | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 2,526,000 | 2,303,897 | 9,496,832 |
| Acquisition Of Business | 0 | 0 | 703,893 |
| Other Investing Activities | — | 2,665,222 | — |
| Cash From Investing Activities | -5,242,000 | -5,606,018 | -11,239,882 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 0 | 9,202,500 | 5,400,000 |
| Repurchase Of Common Stock | 5,000,000 | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 7,857,000 | 2,079,390 | 1,592,714 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -97,949,000 | 1,090,771 | -2,269,778 |
| Change In Cash | 144,934,000 | 18,638,560 | -12,253,208 |
| Cash At End Of Period | 185,574,000 | 40,640,616 | 22,002,056 |
| Income Taxes Paid | 72,815,000 | 798,990 | 849,358 |
| Interest Paid | 2,508,000 | 3,471,708 | 1,639,044 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 11.13 | 10.23 | -0.07 |
| Price To Earnings Ratio | 14.7907 | 3.0978 | -385.6957 |
| Earnings Growth Rate | 8.7977 | -14,714.2857 | -89.5522 |
| Price Earnings To Growth Ratio | 1.6812 | -0.0002 | 4.3069 |
| Book Value Per Share | 66.5632 | 37.0339 | 0.1196 |
| Price To Book Ratio | 2.4731 | 0.8557 | 225.6821 |
| Ebitda | 186,360,000 | 91,799,017 | -11,027,815 |
| Enterprise Value | 904,154,112.74 | 157,547,777.03 | 17,867,956,668.6533 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.129 | 0.2783 | 0.6041 |
| Capital Expenditures | 37,178,256 | 15,517,067 | 16,884,869 |
| Free Cash Flow | 210,946,744 | 7,636,740 | -15,628,417 |
| Return On Equity | 0.2149 | 0.3934 | -0.7451 |
| One Year Beta | 1.4841 | 1.3533 | 0.9962 |
| Three Year Beta | 1.3104 | 1.7209 | 1.2483 |
| Five Year Beta | 1.3094 | 1.1514 | 1.1419 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Jaumot Frank E | Director | 2026-03-20 | 150 | A | 150 |
| Hosseinion Warren | Director, President | 2026-03-19 | 252 | A | 7,765 |
| Spears Kelvin | Director | 2026-03-17 | 10 | A | 32,137 |
| Montgomery Pamela W. | Chief Legal Officer-Healthcare | 2026-03-13 | 79 | A | 2,758 |
| Bates Jon Christian | Chief Financial Officer | 2026-03-11 | 1,694 | A | 5,527 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 3,175,026 | 19,287 | 164.62 |
| World Investment Advisors | 2025-12-31 | 266,304 | 1,618 | 164.5884 |
| Pacer Advisors, Inc. | 2025-12-31 | 5,480,035 | 33,289 | 164.62 |
| Beaird Harris Wealth Management, LLC | 2025-12-31 | 32,924 | 200 | 164.62 |
| Invesco Ltd. | 2025-12-31 | 805,321 | 4,892 | 164.62 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-01-31 | Global X Russell 2000 ETF | RSSL | 1,567 | 233,153.93 | 0.0168 |
| Pacer Funds Trust | 2026-01-31 | Pacer US Small Cap Cash Cows ETF | CALF | 32,109 | 4,777,498.11 | 0.1346 |
| GOLDMAN SACHS TRUST | 2026-01-31 | Class P Shares | GSZPX | 1,110 | 165,156.9 | 0.0721 |
| GOLDMAN SACHS TRUST | 2026-01-31 | Class R6 Shares | GINUX | 1,110 | 165,156.9 | 0.0721 |
| GOLDMAN SACHS TRUST | 2026-01-31 | Investor Shares | GSTOX | 1,110 | 165,156.9 | 0.0721 |